Profile Photo

Katrina "Kat" Martin

Sr Therapeutic Specialty Consultant

Bionephra Pharmaceuticals

Address: Boston, MA
Phone: 800.555.1212
Email: katrina.martin@noemail.com

Ask me about rebates for your diabetic patients on Glucodec SR tablets.

- Kat
Expand All
Click to expand Biography / SummaryUpdated: 04-21-13
Biography / Summary: Katrina "Kat" Martin

Accomplished, results oriented sales professional with successful track record in pharmaceutical sales directed to primary care and specialty providers, academic, endocrine and community hospitals in a challenging managed care environment. Demonstrated success in sales and marketing compliance, sales data analysis, training, knowledge sales force automation software, flexible, organized and self motivated.

- Specialties:Sales Leadership
- Colleague Mentoring
 -Performance-Based Execution
- Consulting
- Strategy Development
 -Public Speaking
- Corporate Integrity Agreements


Click to expand Educational BackgroundUpdated: 04-21-13
Educational Background: Katrina "Kat" Martin
Missouri A&M University: MS, 2001

Educational Background: Katrina "Kat" Martin
Missouri A&M University: BS Biology, 1992 - 1996

Educational Background: Katrina "Kat" Martin
Central High School - Springdale, MO

Click to expand Employment HistoryUpdated: 04-21-13
Employment History: Katrina "Kat" Martin
Senior Therapeutic Specialty Consultant, Bionephra Pharmaceuticals: 2007 - Present

Set daily, weekly, monthly and annual goals through analyzing client/physician prescribing habits which allowed me to attain continued sales success; developed business plans. Worked with medical resident training programs; attended national and international level conventions; set up grand rounds; planned, designed and implemented educational program and used various sales pull through techniques for higher return on investment.

Currently 142% of goal (#1 in the district, #5 in the region (51), #54 in the country (467), trending to win Vice President's Club

Build and foster internal and external business partnerships to support business and professional development. This included working closely with fellow TSR's, marketing team managers and managed care account managers

Responsible for all Brown University teaching hospitals, key federal and state accounts, high volume community hospitals and all endocrinologists

Launched Glucodec with highest market share in the region


Employment History: Katrina "Kat" Martin
Therapeutic Specialty Representative, Bionephra Pharmaceuticals: 2001 - 2007

Employment History: Katrina "Kat" Martin
Pharmaceutical Sales Specialist, Bionephra Pharmaceuticals: 1998 - 2001

Employment History: Katrina "Kat" Martin
Healthcare Representative - Callegra Healthcare: 1996 - 1998

Developed new and maintained existing business in the Primary Care and Community Hospital market
Achieve/exceed quota and/or increase market share for all promoted products
Develop business relationships with office-based physicians, retail and non-retail accounts
Develop a territory business plan, leverage speaker programs and other value-added resources to enhance product growth
Work effectively individually and in a team environment to maximize territory call coverage


Click to expand Committees & BoardsUpdated: 04-21-13
Committees & Boards: Katrina "Kat" Martin
Congressional District Captain (Missouri)

Represented Missouri at the Leaders for Legislative Action Conference Washington, DC, June 2011. Plan quarterly meetings with Missori senators to discuss the topics of healthcare reform and personalized medicine. Selected from among all Missouri Bionephra colleagues to work directly with key Members of Congress on critical Bionephra issues. Responsible for building a relationship with state senators and staff in order to facilitate an ongoing dialogue on Bionephra issues.


Click to expand Continuing Education: CE, CME, CEU...Updated: 04-23-13
Continuing Education: CE, CME, CEU...: Katrina "Kat" Martin

The retina community is experiencing an influx of information for the management and treatment of retinal vein occlusions (RVO) and diabetic macular edema (DME). This assortment of data mainly comes from clinical trials which are designed to test and assess various treatments, provide dosing recommendations, and combinations thereof for different patient populations. This activity will provide retina specialists with these emerging findings and offer opportunities to analyze and discuss this new information as it relates to daily clinical practice and clinical decision-making. This activity will also feature interactive case studies that focus on the practical application of new treatments for patients with RVO and DME.


Johns Hopkins University School of Medicine

Continuing Education: CE, CME, CEU...: Katrina "Kat" Martin
PATIENT WITH DIABETIC MACULAR EDEMA - CASE 4

The retina community is experiencing an influx of information for the management and treatment of retinal vein occlusions (RVO) and diabetic macular edema (DME). This assortment of data mainly comes from clinical trials which are designed to test and assess various treatments, offer dosing recommendations, and combinations thereof for different patient populations. There will be opportunities to analyze and discuss the new data especially as it relates to daily clinical practice and clinical decision-making. This activity features an interactive case study that focuses on the practical application of new treatments for patients with RVO and DME.


Johns Hopkins University School of Medicine

Continuing Education: CE, CME, CEU...: Katrina "Kat" Martin
Evolving Issues in Diabetic Macular Edema: New Medications and Drug Delivery Technologies

Diabetic macular edema (DME) is the major cause of vision loss in people with diabetic retinopathy. In recent years, results from several clinical trials have been published including the Diabetic Retinopathy Clinical Research Network’s “Protocol H” trial, the READ-2 trial, the RESOLVE trial, “Protocol I” trial, RESTORE, and FAME. Furthermore, new delivery system technology has been developed and is being introduced into the armamentarium of clinical practice. Results from several studies assessing the safety and efficacy of steroids using different delivery methods for the management of DME have been recently announced and even more will be announced in the near future. In addition to steroids, results from trials using laser therapy, vascular endothelial growth factor (VEGF) inhibitors and other approaches are breaking into clinical practice. With all these emerging opportunities for DME, it is incumbent on the ophthalmologist to remain well informed and aggressive with rapid diagnosis and optimal treatment.


Johns Hopkins University School of Medicine

Continuing Education: CE, CME, CEU...: Katrina "Kat" Martin
Anticoagulation Continuing Pharmacy Education Activities

The University of Connecticut has developed these web-based continuing pharmacy education activities to enhance the practice of pharmacists and assist pharmacists in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve.  There will be a total of 10 hours of CPE credit available.   Successful completion of these 10  hours (11 activities) or equivalent training will partially prepare the pharmacist for the Anticoagulation Traineeship. 


University of Connecticut School of Pharmacy

Continuing Education: CE, CME, CEU...: Katrina "Kat" Martin
Medication Therapy Management (MTM) for Patients with Diabetes

In this multi-layered, knowledge/application/practice-based continuing pharmacy education activity the University of Connecticut and Drug Topics will develop pharmacist competence in MTM and Motivational Interviewing.  The activity is designed to expand from knowledge-based activities to practice-based skills by properly scaffolding knowledge, application and practice-based learning opportunities with sound instructional design.

The activities will consist of 3 phases designed to build upon each other to provide comprehensive education in the area of diabetes care.  Pharmacists may participate at any level of education that meets their needs, however, a Practice-based Certificate of Achievement will be awarded to those who have completed all phases of the education.


University of Connecticut School of Pharmacy

Continuing Education: CE, CME, CEU...: Katrina "Kat" Martin
Methadone and Oral Health

Methadone is a prescription drug used to help individuals overcome withdraws from highly addictive illicit substances, such as heroin, but it has detrimental oral health effects. This manuscript reviews the oral health manifestations of methadone maintenance therapy, and considers its implications to oral care. It hopes to raise awareness among health care professionals, regulating bodies and the population at large about the oral side effects of methadone, the implications for dental treatment and considerations to better enhance the oral health of methadone users. The role of professional teams, particularly dentists and dental hygienists, is illustrated.


American Dental Hygienists' Association

Continuing Education: CE, CME, CEU...: Katrina "Kat" Martin
Shifting Paradigms in Type 2 Diabetes: Managed Care Perspectives

University of Tennessee Advanced Studies in Pharmacy

Continuing Education: CE, CME, CEU...: Katrina "Kat" Martin
Diabetes Mellitus: Promoting Collaboration Among Health Care Professionals

Diabetes mellitus is a serious chronic disease that has reached epidemic proportions in the United States. The consequences of the disease are significant and costly. Managing this condition effectively requires the commitment of all health care providers, including oral health professionals. The purpose of this paper is to provide an overview of diabetes mellitus and specific concepts related to eye care, foot care, oral care, and medication management. Implications for dental hygiene practice and guidelines for providing oral health care working in collaboration with other health care providers are addressed. - See more at: http://adha.cdeworld.com/courses/20002#sthash.yylL4GJu.dpuf


American Dental Hygienists' Association

Click to expand PublicationsUpdated: 04-23-13
Publications: Katrina "Kat" Martin
My Suggested Publications:

Publications: Katrina "Kat" Martin
Adult-onset type 1 diabetes and pregnancy: three case reports.

PubMed

Publications: Katrina "Kat" Martin
From intervention to innovation: applying a formal implementation strategy in community primary care.

PubMed

Publications: Katrina "Kat" Martin
A study of bone mineral density and its determinants in type 1 diabetes mellitus.

PubMed

Publications: Katrina "Kat" Martin
Amylin Uncovered: A Review on the Polypeptide Responsible for Type II Diabetes

PubMed

Click to expand Honors & AwardsUpdated: 04-23-13
Honors & Awards: Katrina "Kat" Martin

- Vice Presidents Cabinet Award, Bionephra Pharmacuticals
- Circle of Excellence Award, Bionephra Pharmacuticals
- District Representative of the Year, Bionephra Pharmacuticals


Click to expand Publication, Trade Journal & Periodical SubscriptionsUpdated: 04-23-13
Publication, Trade Journal & Periodical Subscriptions: Katrina "Kat" Martin
Diabetes

Diabetes publishes original research about the physiology and pathophysiology of diabetes mellitus. Submitted manuscripts can report any aspect of laboratory, animal, or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic pancreatic islet function and intermediary metabolism, pharmacological mechanisms of drug and hormone action, and biochemical and molecular aspects of normal and abnormal biological processes. Studies in the areas of diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus are not published.


Diabetes (American Diabetes Association)

Publication, Trade Journal & Periodical Subscriptions: Katrina "Kat" Martin
Diabetic Living

Diabetic Living

Click to expand REMS Enrollments/Training (Risk Evaluation & Mitigation Strategies)Updated: 04-22-13

A Risk Evaluation and Mitigation Strategy (REMS) is a strategy to manage a known or potential serious risk associated with a drug or biological product. A REMS will be required if the Food and Drug Administration (FDA) determines that a REMS is necessary to ensure the benefits of the drug or biological product outweigh its risks. A REMS can include a Medication Guide, Patient Package Insert, a communication plan, elements to assure safe use, and an implementation system.

REMS Enrollments/Training (Risk Evaluation & Mitigation Strategies): Katrina "Kat" Martin
REMS Enrollments/Training (Risk Evaluation & Mitigation Strategies): Katrina "Kat" Martin
Click to expand MOOCs Taken (Massive Open Online Courses)Updated: 04-24-13
MOOCs Taken (Massive Open Online Courses): Katrina "Kat" Martin
Writing Workshop - MIT (Massachusetts Institute of Technology): Currently Enrolled

MIT students are challenged daily to solve for x, to complete four problem sets, two papers, and prepare for an exam worth 30% of their grade... all in one night. When they do stop to breathe, it's for a shower or a meal. What does this have to do with creative writing? Everything. Creative writing and MIT go together better than you might imagine.


MIT (Massachusetts Institute of Technology) - MIT OpenCourseWare

Click to expand AthleticsUpdated: 04-22-13
Athletics: Katrina "Kat" Martin
Running History

These are the races I have run to date:

Half-Marathons

  1. Mohawk-Hudson Half Marathon  2005
  2. Long Branch Half Marathon 2007
  3. Lake Placid Half Marathon 2007

Marathons

  1.  Walt Disney World Marathon 2006
  2. Key Bank Vermont City Marathon 2007
  3. Mohawk-Hudson River Marathon & Half Marathon 2007
  4. Yuengling Shamrock Sportsfest Marathon 2009
  5. San Diego Rock 'n' Roll Marathon 2010
  6. Somerville Road Runners Around the Lake Marathon 2010
  7. Erie Marathon at Presque Isle 2010
  8. Mohawk-Hudson River Marathon 2010
  9. Philadelphia Marathon 2010
  10. Disney World Marathon and a Half Goofy Challenge 2011

Click to expand Fraternal OrganizationsUpdated: 04-24-13
Fraternal Organizations: Katrina "Kat" Martin
Sigma Kappa


Purpose Statement
The purpose of Sigma Kappa Sorority is to provide women lifelong opportunities and support for social, intellectual and spiritual development by bringing women together to positively impact our communities.

Sigma Kappa's Values
The values of Sigma Kappa are personal growth, friendship, service and loyalty; bound by a promise.

Personal growth
Bound by a Promise to be the best person you can be.
-Social: Demonstrating leadership through behaviors that are in alignment with the Sorority's values
-Intellectual: Committing to a lifetime of learning and enrichment
-Spiritual: Striving to live a purposeful life

Service
Bound by a Promise to model service and leadership in your communities, especially within Sigma Kappa.
Offering your time, ideas or resources to support the common good and assist those in need.

Friendship
Bound by a Promise to demonstrate sisterhood and friendship throughout life.

Sisterhood, Self-respect, Mutual respect

Loyalty
Bound by a Promise to remain loyal to Sigma Kappa and to living its values in all that you do.


SK Website

Click to unlock with View Code. Recommendations & ReferencesUpdated: 04-11-13
Click to unlock with View Code. TranscriptsUpdated: 04-11-13
Click to unlock with View Code. Competency AssessmentsUpdated: 04-23-13
Click to unlock with View Code. Immunization HistoryUpdated: 04-23-13
Click to unlock with View Code. CPD Plan Management: EVALUATIONUpdated: 04-24-13
Click to unlock with View Code. CPD Plan Management: PLANNINGUpdated: 04-24-13
Click to unlock with View Code. CPD Plan Management: ACTION / LEARNINGUpdated: 04-24-13
Click to unlock with View Code. CPD Plan Management: REFLECTIONUpdated: 04-24-13
Profile Photo